Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6353265 | 0.93 | HPGD (0.33) | HPGDKMT2A | |
| SCHEMBL11358287 | 0.80 | CYP2D6 (0.36) | — | |
| SCHEMBL5704095 | 0.79 | NOTUM (0.32) | — | |
| SCHEMBL11142330 | 0.77 | NOTUM (0.31) | — | |
| SCHEMBL130272 | 0.76 | THRB (0.32) | ALDH1A1 | |
| SCHEMBL6361567 | 0.75 | — | — | |
| SCHEMBL709529 | 0.75 | ALDH1A1 (0.31) | KMT2AALDH1A1ATM | |
| SCHEMBL4600849 | 0.73 | TSHR (0.38) | ALDH1A1MAPTHTT | |
| SCHEMBL9416551 | 0.73 | GSTP1 (0.30) | — | |
| SCHEMBL9416553 | 0.73 | GSTP1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050124829-A1 | Brominated esters, methods for their preparation and use thereof as flame retardants | BROMINE COMPOUNDS LTD. (IL) | 2005-06-09 | — | — | US | disclosed |
| EP-1478615-A1 | BROMINATED ESTERS, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FLAME RETARDANTS | Bromine Compounds Ltd. (IL) | 2004-11-24 | — | — | EP | disclosed |
| WO-2003070685-A1 | BROMINATED ESTERS, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FLAME RETARDANTS | BROMINE COMPOUNDS LTD. (IL) | 2003-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124829-A1 | Brominated esters, methods for their preparation and use thereof as flame retardants | CYP2F1, POLL, EBP | HPGD 2186/4885KMT2A 1029/4885ALDH1A1 1209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.